Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisabetta Ferraro

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
Human Immunology|May 14, 2011
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control studySara Galluzzo, Giuseppe Patti, Giordano Dicuonzo, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
Occupational stress and personality traits in multiple sclerosis: A preliminary studyChiara Concetta Incerti, Giuseppe Magistrale, Ornella Argento, et al.
The FEBS Journal|August 20, 2013
The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubesElisabetta Ferraro, Anna Maria Giammarioli, Sara Caldarola, et al.
Frontiers in Public Health|August 16, 2021
One Health Evaluation: A Case Study at the University of BolognaMaurizio Aragrande, Massimo Canali, Mariana Roccaro, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2009
Apoptosis is not required for mammalian neural tube closureValentina Massa, Dawn Savery, Patricia Ybot-Gonzalez, et al.
Cancer & Metabolism|January 3, 2024
Assessment of lipolysis biomarkers in adipose tissue of patients with gastrointestinal cancerFederica Tambaro, Giovanni Imbimbo, Elisabetta Ferraro, et al.
Clinical Neurology and Neurosurgery|September 3, 2020
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferonFioravante Capone, Antonio De Vincentis, Elisabetta Ferraro, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 14, 2017
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing miceFrancesca Molinari, Fabrizio Pin, Stefania Gorini, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|April 4, 2025
Deciphering Facioscapulohumeral Dystrophy in the clinical trials era: where are we now?Francesca Torri, Beatrice Ciurli, Mariaconcetta Rende, et al.
Scientific Reports|November 18, 2023
Anti-inflammatory reprogramming of microglia cells by metabolic modulators to counteract neurodegeneration; a new role for RanolazineIlaria Piano, Arianna Votta, Patrizia Colucci, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
Human Immunology|May 14, 2011
Association between NOD2/CARD15 polymorphisms and coronary artery disease: a case-control studySara Galluzzo, Giuseppe Patti, Giordano Dicuonzo, et al.
Multiple Sclerosis and Related Disorders|July 22, 2015
Occupational stress and personality traits in multiple sclerosis: A preliminary studyChiara Concetta Incerti, Giuseppe Magistrale, Ornella Argento, et al.
The FEBS Journal|August 20, 2013
The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubesElisabetta Ferraro, Anna Maria Giammarioli, Sara Caldarola, et al.
Frontiers in Public Health|August 16, 2021
One Health Evaluation: A Case Study at the University of BolognaMaurizio Aragrande, Massimo Canali, Mariana Roccaro, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 8, 2009
Apoptosis is not required for mammalian neural tube closureValentina Massa, Dawn Savery, Patricia Ybot-Gonzalez, et al.
Cancer & Metabolism|January 3, 2024
Assessment of lipolysis biomarkers in adipose tissue of patients with gastrointestinal cancerFederica Tambaro, Giovanni Imbimbo, Elisabetta Ferraro, et al.
Clinical Neurology and Neurosurgery|September 3, 2020
The PNPLA3 rs738409 variant can increase the risk of liver toxicity in multiple sclerosis patients treated with beta-interferonFioravante Capone, Antonio De Vincentis, Elisabetta Ferraro, et al.
Journal of Cachexia, Sarcopenia and Muscle|November 14, 2017
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing miceFrancesca Molinari, Fabrizio Pin, Stefania Gorini, et al.
Acta Myologica : Myopathies and Cardiomyopathies : Official Journal of the Mediterranean Society of Myology|April 4, 2025
Deciphering Facioscapulohumeral Dystrophy in the clinical trials era: where are we now?Francesca Torri, Beatrice Ciurli, Mariaconcetta Rende, et al.
Scientific Reports|November 18, 2023
Anti-inflammatory reprogramming of microglia cells by metabolic modulators to counteract neurodegeneration; a new role for RanolazineIlaria Piano, Arianna Votta, Patrizia Colucci, et al.
Pageof 9